ClinicalTrials.Veeva

Menu
M

Midwest Cardiovascular Research and Education Foundation | Elkhart, IN

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Empagliflozin
Aspirin
Plozasiran
Finerenone
Obicetrapib
Prasugrel
EMPagliflozin
lisinopril
Evolocumab
losartan

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 13 total trials

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease (PREVAIL)

This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with Atherosclerotic Cardiovascular Disease (ASCVD)...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Obicetrapib
Drug: Placebo

This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with hypertriglyceridemia (HTG). A...

Enrolling
Hypertriglyceridemia
Drug: Placebo
Drug: Plozasiran Injection

This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with severe hypertriglyceridemia (...

Enrolling
Severe Hypertriglyceridemia
Drug: Placebo
Drug: Plozasiran Injection

Trial sponsors

Boehringer Ingelheim logo
Arrowhead Pharmaceuticals logo
Bayer logo
Amgen logo
B
N
University of British Columbia logo
University of Florida logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems